Clinical appraisal of handheld intestinal ultrasound in inflammatory bowel disease: Where are we now?
Related Experiment Video
Updated: Aug 9, 2026

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Yusuke Miyatani1, Alexandra Hudson2, Amelia Kellar3,4
1Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, United States.
Abstract:
Gastroenterologist-performed intestinal ultrasound (IUS) is increasingly used to monitor inflammatory bowel disease (IBD) due to its noninvasive, real-time, and cost-effective attributes, alongside high diagnostic accuracy. However, wider adoption remains limited by the cost, size, and workflow demands of cart-based or high-end ultrasound platforms. Handheld ultrasound has emerged as a miniaturized alternative that can be and applied at the bedside. Early studies of handheld intestinal ultrasound (HHIUS) in IBD have demonstrated reproducibility and diagnostic performance comparable to conventional IUS for selected applications, particularly bowel wall thickness assessment, with limitations in assessing deep pelvic lesion and complications. Whereas interdevice comparisons specific to IBD are lacking, data from general medicine suggest rapid improvements in image quality and usability of handheld devices. However, most comparative studies have not evaluated color Doppler, a core IUS parameter. In ulcerative colitis, Doppler-inclusive assessment using the Milan Ultrasound Criteria appears feasible with HHIUS, whereas color Doppler performance in Crohn's disease remains insufficiently validated. Hardware accessibility alone does not ensure IUS competency. Safe implementation requires structured training, including supervised practice, image quality review, and feedback, which may be supplemented by real-time telementoring and artificial intelligence. Taken together, HHIUS may be best positioned as a complementary bedside adjunct for triage, focused assessment, selected monitoring, resource-limited settings, and education, with predefined escalation to conventional IUS, magnetic resonance enterography/computed tomography, or endoscopic reassessment when appropriate. Future studies are needed to evaluate color Doppler performance, interdevice reproducibility, and safe integration of HHIUS into clinical workflows and training programs.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
